In addition, FAP has been reported to be overexpressed in a variety of cancers, such as lung, breast, and colorectal, making it an attractive antigen for the simultaneous targeting of tumor cells and respective CAFs present within the TME [45–47]. This evidence concerns the gene FAP and neoplasm.